Lapiferin - Compound Card

Lapiferin

Select a section from the left sidebar

Lapiferin

Structure
Zoomed Structure
  • Family: Plantae - Apiaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Carotene Sesquiterpene
Canonical Smiles C/C=C(\C(=O)O[C@H]1C[C@@]2(C)O[C@H]2[C@H]([C@@]2([C@@H]1[C@@](O)(CC2)C(C)C)C)OC(=O)C)/C
InChI InChI=1S/C22H34O6/c1-8-13(4)19(24)27-15-11-21(7)18(28-21)17(26-14(5)23)20(6)9-10-22(25,12(2)3)16(15)20/h8,12,15-18,25H,9-11H2,1-7H3/b13-8-/t15-,16+,17+,18-,20-,21+,22+/m0/s1
InChIKey WVPPLOSRTXOZAP-TWDKUCNPSA-N
Formula C22H34O6
HBA 6
HBD 1
MW 394.51
Rotatable Bonds 4
TPSA 85.36
LogP 3.16
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 28
Formal Charge 0
Fraction CSP3 0.82
Exact Mass 394.24
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Ferula vesceritensis Apiaceae Plantae 1514058

Showing of synonyms

  • Gamal-Eldeen AM, Hegazy ME (2010). A crystal lapiferin derived from Ferula vesceritensis induces apoptosis pathway in MCF-7 breast cancer cells.. Natural Product Research,2010,24(3),246-257. [View] [PubMed]
Pubchem: 40565714
Nmrshiftdb2: 70111808
CPRiL: 55068
Structure

SMILES: C12C(O2)CCC3C(C1)CCC3

Level: 0

Mol. Weight: 394.51 g/mol

Anticancer

Absorption

Caco-2 (logPapp)
-5.09
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.66
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.67

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.35
Plasma Protein Binding
48.01
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
14.25
Organic Cation Transporter 2
Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.67
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.0
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
5.52
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-10.73
Rat (Acute)
4.26
Rat (Chronic Oral)
1.56
Fathead Minnow
3.95
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
380.3
Hydration Free Energy
-4.85
Log(D) at pH=7.4
2.22
Log(P)
3.34
Log S
-3.7
Log(Vapor Pressure)
-6.36
Melting Point
104.62
pKa Acid
6.79
pKa Basic
3.49

No predicted protein targets found for this compound.

Download SDF